Expertise in
2
conditions

Yida S. Yang

State Key Laboratory For Diagnosis And Treatment Of Infectious Diseases, 
Hangzhou, CN 
Expertise in
2
conditions
State Key Laboratory For Diagnosis And Treatment Of Infectious Diseases, 
Hangzhou, CN 

Overview

Yida Yang practices practicing medicine in Hangzhou, China.

Yang is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Gastrointestinal Bleeding, Hepatitis B, Cirrhosis, and Hepatitis.

They are actively involved in clinical research, co-authoring 56 peer reviewed articles and participating in 2 clinical trials.

Locations

State Key Laboratory For Diagnosis And Treatment Of Infectious Diseases, Hangzhou, China
Other Locations
Chongqing, 400038, China
Beijing, 100190, China
Changchun, 130041, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Prospective, Randomized, Controlled Clinical Trial to Evaluate the Role of Peg-IFN Alfa-2a in Reducing RelapSe Rate in Patients With Hepatitis B e Antigen(HBeAg)-nEgative Chronic Hepatitis B After Discontinuation of NUC Therapy
A Prospective, Randomized, Controlled Clinical Trial to Evaluate the Role of Peg-IFN Alfa-2a in Reducing RelapSe Rate in Patients With Hepatitis B e Antigen(HBeAg)-nEgative Chronic Hepatitis B After Discontinuation of NUC Therapy
Enrollment Status: Completed
Publish Date: October 31, 2022
Intervention Type: Drug
Study Drug: PegIFN alfa-2a
Study Phase: Phase 4
A Real-world Clinical Study on Effectiveness and Safety of Long-term TAF Treatment in Chronic Hepatitis B Patients in China
A Real-world Clinical Study on Effectiveness and Safety of Long-term TAF Treatment in Chronic Hepatitis B Patients in China
Enrollment Status: Unknown
Publish Date: November 26, 2019
Intervention Type: Drug
View 1 Less Clinical Trial

56 Total Publications

Characterization of the intrahepatic microbiome in patients with HBV-related end-stage liver disease.
Characterization of the intrahepatic microbiome in patients with HBV-related end-stage liver disease.
Journal: Virulence
Published: April 27, 2026

Frequently Asked Questions about Yida S. Yang

Is Yida S. Yang a top-rated expert for Gastrointestinal Bleeding?

MediFind is an objective health platform that identifies experts based on real-world data. Yida S. Yang is classified as an Advanced expert for Gastrointestinal Bleeding, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yida S. Yang participate in research or clinical trials?

Yes. Yida S. Yang has published 56 articles and abstracts on conditions like Gastrointestinal Bleeding. You can view a list of Yida S. Yang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yang's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile